TESOFENSINE SOURCES
PHARMACOLOGICAL PROFILE AND MECHANISM OF ACTION
Details: PubChem provides extensive chemical data, including Tesofensine’s molecular structure, physical properties, and biological activities. The compound acts by inhibiting the reuptake of three key neurotransmitters: serotonin, norepinephrine, and dopamine. This leads to elevated levels of these neurotransmitters in the synaptic cleft, resulting in appetite suppression, increased metabolism, and enhanced energy expenditure.
SOURCE: PubChem
SCIENCEDIRECT OVERVIEW
Details: ScienceDirect outlines the pharmacological action of Tesofensine, emphasizing its triple reuptake inhibition mechanism. By enhancing neurotransmitter levels, Tesofensine not only reduces appetite but also positively influences mood and cognitive function, making it a unique compound in obesity research.
SOURCE: ScienceDirect
CLINICAL TRIALS AND EFFICACY PHASE II CLINICAL TRIAL
Study Title: “Tesofensine, a Novel Triple Monoamine Reuptake Inhibitor, Induces Significant Weight Loss in Obese Patients: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial”
Details: This pivotal Phase II clinical trial demonstrated that Tesofensine led to an average weight loss of approximately 10% of body weight over a 24-week period, compared to 2% in the placebo group. The trial highlighted Tesofensine’s potential as a highly effective weight loss agent, with minimal adverse effects reported at lower doses.
SOURCE: Nature
CLINICAL TRIALS ARENA REPORT
Study Title: “Tesofensine, a Novel Antiobesity Drug, Silences GABAergic Hypothalamic Neurons”
Details: This study investigated Tesofensine’s impact on GABAergic neurons in the lateral hypothalamus of rats. The findings revealed that Tesofensine suppresses the activity of neurons responsible for promoting feeding behavior. As a result, rats treated with Tesofensine exhibited reduced food intake and significant weight loss. The study also highlighted Tesofensine’s ability to maintain long-term weight reduction by preventing rebound weight gain.
SOURCE: PLOS ONE
SAFETY AND SIDE EFFECTS GENEMEDICS HEALTH INSTITUTE OVERVIEW
Details: Genemedics provides a detailed analysis of Tesofensine’s safety profile. While the compound is generally well-tolerated, common side effects observed in clinical trials include mild insomnia, dry mouth, and increased heart rate. The report also notes that lower doses tend to minimize these adverse effects while maintaining efficacy.
SOURCE: Genemedics